BioXcel Therapeutics
BTAI
#9513
Rank
A$40.53 M
Marketcap
$0.99
Share price
2.37%
Change (1 day)
-86.48%
Change (1 year)

Earnings for BioXcel Therapeutics (BTAI)

Earnings in 2024 (TTM): -A$0.15 Billion

According to BioXcel Therapeutics's latest financial reports the company's current earnings are A$2.4 Million. In 2023 the company made an earning of -A$0.25 Billion a decrease over its 2022 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioXcel Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.15 Billion-42.52%
2023 -A$0.25 Billion5.94%
2022 -A$0.24 Billion46.34%
2021 -A$0.17 Billion30.14%
2020 -A$0.13 Billion145.44%
2019 -A$50.44 Million67.65%
2018 -A$30.09 Million339.98%
2017 -A$6.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.19 Billion 33.33%๐Ÿ‡บ๐Ÿ‡ธ USA